Annual FCF
-$13.33 M
+$2.68 M+16.74%
December 31, 2021
Summary
- As of February 8, 2025, VIVE annual free cash flow is -$13.33 million, with the most recent change of +$2.68 million (+16.74%) on December 31, 2021.
- During the last 3 years, VIVE annual FCF has risen by +$31.90 million (+70.52%).
- VIVE annual FCF is now -519.57% below its all-time high of $3.18 million, reached on December 31, 2004.
Performance
VIVE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$3.54 M
+$1.08 M+23.43%
September 30, 2022
Summary
- As of February 8, 2025, VIVE quarterly free cash flow is -$3.54 million, with the most recent change of +$1.08 million (+23.43%) on September 30, 2022.
- Over the past year, VIVE quarterly FCF has dropped by -$796.00 thousand (-28.98%).
- VIVE quarterly FCF is now -151.08% below its all-time high of $6.94 million, reached on June 30, 2005.
Performance
VIVE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$16.83 M
-$796.00 K-4.97%
September 30, 2022
Summary
- As of February 8, 2025, VIVE TTM free cash flow is -$16.83 million, with the most recent change of -$796.00 thousand (-4.97%) on September 30, 2022.
- Over the past year, VIVE TTM FCF has dropped by -$4.34 million (-34.73%).
- VIVE TTM FCF is now -312.78% below its all-time high of $7.91 million, reached on March 31, 2006.
Performance
VIVE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
VIVE Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.7% | -29.0% | -34.7% |
| 3 y3 years | +70.5% | +47.4% | +47.9% |
| 5 y5 years | +62.7% | +62.1% | +47.9% |
VIVE Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -0.6% | +31.0% | -26.2% | at low |
| 5 y | 5-year | at high | +58.8% | -32.4% | +39.9% | -34.7% | +47.9% |
| alltime | all time | -519.6% | +70.5% | -151.1% | +77.4% | -312.8% | +62.8% |
Viveve Medical Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$3.54 M(-23.4%) | -$16.83 M(+5.0%) |
| Jun 2022 | - | -$4.63 M(-9.9%) | -$16.03 M(+5.9%) |
| Mar 2022 | - | -$5.14 M(+45.9%) | -$15.13 M(+13.5%) |
| Dec 2021 | -$13.33 M(-16.7%) | -$3.52 M(+28.2%) | -$13.33 M(+6.8%) |
| Sep 2021 | - | -$2.75 M(-26.3%) | -$12.49 M(-0.9%) |
| Jun 2021 | - | -$3.73 M(+11.7%) | -$12.60 M(-6.4%) |
| Mar 2021 | - | -$3.34 M(+24.7%) | -$13.46 M(-16.0%) |
| Dec 2020 | -$16.02 M(-50.5%) | -$2.68 M(-6.4%) | -$16.02 M(-15.5%) |
| Sep 2020 | - | -$2.86 M(-37.7%) | -$18.95 M(-17.0%) |
| Jun 2020 | - | -$4.58 M(-22.3%) | -$22.83 M(-13.8%) |
| Mar 2020 | - | -$5.90 M(+5.1%) | -$26.48 M(-18.1%) |
| Dec 2019 | -$32.32 M(-28.5%) | -$5.61 M(-16.7%) | -$32.32 M(-14.3%) |
| Sep 2019 | - | -$6.74 M(-18.2%) | -$37.71 M(-8.4%) |
| Jun 2019 | - | -$8.23 M(-29.8%) | -$41.17 M(-0.4%) |
| Mar 2019 | - | -$11.74 M(+6.7%) | -$41.32 M(-8.7%) |
| Dec 2018 | -$45.23 M(+26.5%) | -$11.00 M(+8.0%) | -$45.23 M(+5.4%) |
| Sep 2018 | - | -$10.19 M(+21.6%) | -$42.90 M(+2.0%) |
| Jun 2018 | - | -$8.38 M(-46.4%) | -$42.06 M(-2.7%) |
| Mar 2018 | - | -$15.65 M(+80.5%) | -$43.21 M(+20.8%) |
| Dec 2017 | -$35.76 M(+94.9%) | -$8.67 M(-7.3%) | -$35.76 M(+8.3%) |
| Sep 2017 | - | -$9.35 M(-1.9%) | -$33.01 M(+11.4%) |
| Jun 2017 | - | -$9.53 M(+16.2%) | -$29.64 M(+21.2%) |
| Mar 2017 | - | -$8.20 M(+38.4%) | -$24.46 M(+33.3%) |
| Dec 2016 | -$18.34 M(+49.1%) | -$5.92 M(-0.9%) | -$18.34 M(+12.2%) |
| Sep 2016 | - | -$5.98 M(+37.4%) | -$16.34 M(+19.6%) |
| Jun 2016 | - | -$4.35 M(+108.8%) | -$13.67 M(+7.5%) |
| Mar 2016 | - | -$2.08 M(-46.9%) | -$12.71 M(+3.3%) |
| Dec 2015 | -$12.30 M(+101.4%) | -$3.93 M(+18.9%) | -$12.30 M(+19.1%) |
| Sep 2015 | - | -$3.30 M(-2.8%) | -$10.33 M(+3.2%) |
| Jun 2015 | - | -$3.40 M(+103.0%) | -$10.01 M(+39.9%) |
| Mar 2015 | - | -$1.67 M(-14.2%) | -$7.15 M(+17.1%) |
| Dec 2014 | -$6.11 M(+27.1%) | -$1.95 M(-34.6%) | -$6.11 M(+28.0%) |
| Sep 2014 | - | -$2.98 M(+448.3%) | -$4.77 M(+53.5%) |
| Jun 2014 | - | -$544.00 K(-13.8%) | -$3.11 M(-5.1%) |
| Mar 2014 | - | -$631.00 K(+2.8%) | -$3.28 M(-31.8%) |
| Dec 2013 | -$4.80 M(+48.3%) | -$614.00 K(-53.5%) | -$4.80 M(+0.3%) |
| Sep 2013 | - | -$1.32 M(+85.4%) | -$4.79 M(+4.8%) |
| Jun 2013 | - | -$712.00 K(-67.0%) | -$4.57 M(+2.8%) |
| Mar 2013 | - | -$2.16 M(+259.1%) | -$4.45 M(+37.3%) |
| Dec 2012 | -$3.24 M(-5.0%) | -$601.00 K(-45.4%) | -$3.24 M(-0.9%) |
| Sep 2012 | - | -$1.10 M(+86.8%) | -$3.27 M(+8.3%) |
| Jun 2012 | - | -$589.00 K(-37.9%) | -$3.02 M(-17.4%) |
| Mar 2012 | - | -$949.00 K(+50.4%) | -$3.65 M(+7.7%) |
| Dec 2011 | -$3.41 M(+153.0%) | -$631.00 K(-25.8%) | -$3.39 M(+22.9%) |
| Sep 2011 | - | -$850.00 K(-30.6%) | -$2.76 M(+29.9%) |
| Jun 2011 | - | -$1.23 M(+78.3%) | -$2.13 M(+74.3%) |
| Mar 2011 | - | -$687.00 K(<-9900.0%) | -$1.22 M(-9.5%) |
| Dec 2010 | -$1.35 M(-43.2%) | $1000.00(-100.5%) | -$1.35 M(-29.2%) |
| Sep 2010 | - | -$215.00 K(-32.6%) | -$1.91 M(-5.4%) |
| Jun 2010 | - | -$319.00 K(-60.9%) | -$2.01 M(-19.4%) |
| Mar 2010 | - | -$815.00 K(+46.6%) | -$2.50 M(+5.2%) |
| Dec 2009 | -$2.37 M(-20.8%) | -$556.00 K(+72.1%) | -$2.37 M(+3.3%) |
| Sep 2009 | - | -$323.00 K(-59.7%) | -$2.30 M(+19.1%) |
| Jun 2009 | - | -$802.00 K(+15.9%) | -$1.93 M(-21.5%) |
| Mar 2009 | - | -$692.00 K(+44.2%) | -$2.46 M(-18.0%) |
| Dec 2008 | -$3.00 M(+49.6%) | -$480.00 K(-1166.7%) | -$3.00 M(-5.6%) |
| Sep 2008 | - | $45.00 K(-103.4%) | -$3.18 M(+0.2%) |
| Jun 2008 | - | -$1.33 M(+8.0%) | -$3.17 M(-3.2%) |
| Mar 2008 | - | -$1.23 M(+86.9%) | -$3.27 M(+63.5%) |
| Dec 2007 | -$2.00 M | -$659.00 K(-1367.3%) | -$2.00 M(+24.2%) |
| Sep 2007 | - | $52.00 K(-103.6%) | -$1.61 M(-11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | -$1.44 M(-3690.0%) | -$1.82 M(+186.8%) |
| Mar 2007 | - | $40.00 K(-114.9%) | -$634.00 K(-261.7%) |
| Dec 2006 | $392.00 K(-313.0%) | -$269.00 K(+75.8%) | $392.00 K(-1.0%) |
| Sep 2006 | - | -$153.00 K(-39.3%) | $396.00 K(-45.0%) |
| Jun 2006 | - | -$252.00 K(-123.6%) | $720.00 K(-90.9%) |
| Mar 2006 | - | $1.07 M(-502.3%) | $7.91 M(-4397.8%) |
| Dec 2005 | -$184.00 K(-105.8%) | -$265.00 K(-255.0%) | -$184.00 K(-69.1%) |
| Sep 2005 | - | $171.00 K(-97.5%) | -$596.00 K(-15.6%) |
| Jun 2005 | - | $6.94 M(-198.7%) | -$706.00 K(-91.5%) |
| Mar 2005 | - | -$7.03 M(+937.8%) | -$8.27 M(-360.4%) |
| Dec 2004 | $3.18 M(+515.9%) | -$677.00 K(-1209.8%) | $3.18 M(-22.2%) |
| Sep 2004 | - | $61.00 K(-109.7%) | $4.09 M(-5.7%) |
| Jun 2004 | - | -$632.00 K(-114.3%) | $4.33 M(-20.7%) |
| Mar 2004 | - | $4.43 M(+1816.0%) | $5.47 M(+959.5%) |
| Dec 2003 | $516.00 K(-44.8%) | $231.00 K(-25.5%) | $516.00 K(-32.9%) |
| Sep 2003 | - | $310.00 K(-38.0%) | $769.00 K(+22.5%) |
| Jun 2003 | - | $500.00 K(-195.2%) | $628.00 K(+290.1%) |
| Mar 2003 | - | -$525.00 K(-208.5%) | $161.00 K(-82.8%) |
| Dec 2002 | $935.00 K(-119.4%) | $484.00 K(+186.4%) | $935.00 K(-359.0%) |
| Sep 2002 | - | $169.00 K(+412.1%) | -$361.00 K(-64.2%) |
| Jun 2002 | - | $33.00 K(-86.7%) | -$1.01 M(-54.0%) |
| Mar 2002 | - | $249.00 K(-130.7%) | -$2.19 M(-54.5%) |
| Dec 2001 | -$4.82 M(+47.4%) | -$812.00 K(+69.5%) | -$4.82 M(+25.9%) |
| Sep 2001 | - | -$479.00 K(-58.3%) | -$3.83 M(-8.9%) |
| Jun 2001 | - | -$1.15 M(-51.6%) | -$4.20 M(-0.6%) |
| Mar 2001 | - | -$2.38 M(-1427.4%) | -$4.23 M(+29.4%) |
| Dec 2000 | -$3.27 M(-34.1%) | $179.00 K(-121.0%) | -$3.27 M(-33.4%) |
| Sep 2000 | - | -$854.00 K(-27.4%) | -$4.91 M(+3.2%) |
| Jun 2000 | - | -$1.18 M(-16.9%) | -$4.75 M(-13.2%) |
| Mar 2000 | - | -$1.42 M(-2.9%) | -$5.47 M(+10.4%) |
| Dec 1999 | -$4.96 M(-70.7%) | -$1.46 M(+108.4%) | -$4.96 M(-30.2%) |
| Sep 1999 | - | -$700.00 K(-63.2%) | -$7.10 M(-37.2%) |
| Jun 1999 | - | -$1.90 M(+111.1%) | -$11.30 M(-21.5%) |
| Mar 1999 | - | -$900.00 K(-75.0%) | -$14.40 M(-14.8%) |
| Dec 1998 | -$16.90 M(+33.1%) | -$3.60 M(-26.5%) | -$16.90 M(-1.7%) |
| Sep 1998 | - | -$4.90 M(-2.0%) | -$17.20 M(+23.7%) |
| Jun 1998 | - | -$5.00 M(+47.1%) | -$13.90 M(+7.8%) |
| Mar 1998 | - | -$3.40 M(-12.8%) | -$12.90 M(+1.6%) |
| Dec 1997 | -$12.70 M(+1054.5%) | -$3.90 M(+143.8%) | -$12.70 M(+5.8%) |
| Sep 1997 | - | -$1.60 M(-60.0%) | -$12.00 M(-5.5%) |
| Jun 1997 | - | -$4.00 M(+25.0%) | -$12.70 M(+22.1%) |
| Mar 1997 | - | -$3.20 M(0.0%) | -$10.40 M(+845.5%) |
| Dec 1996 | -$1.10 M(-77.1%) | -$3.20 M(+39.1%) | -$1.10 M(-152.4%) |
| Sep 1996 | - | -$2.30 M(+35.3%) | $2.10 M(-52.3%) |
| Jun 1996 | - | -$1.70 M(-127.9%) | $4.40 M(-27.9%) |
| Mar 1996 | - | $6.10 M(-3150.0%) | $6.10 M(-421.1%) |
| Dec 1995 | -$4.80 M(+152.6%) | - | - |
| Dec 1994 | -$1.90 M(-50.0%) | -$200.00 K(-80.0%) | -$1.90 M(-13.6%) |
| Sep 1994 | - | -$1.00 M(+400.0%) | -$2.20 M(0.0%) |
| Jun 1994 | - | -$200.00 K(-60.0%) | -$2.20 M(-29.0%) |
| Mar 1994 | - | -$500.00 K(0.0%) | -$3.10 M(-18.4%) |
| Dec 1993 | -$3.80 M(+11.8%) | -$500.00 K(-50.0%) | -$3.80 M(-19.1%) |
| Sep 1993 | - | -$1.00 M(-9.1%) | -$4.70 M(+23.7%) |
| Jun 1993 | - | -$1.10 M(-8.3%) | -$3.80 M(+5.6%) |
| Mar 1993 | - | -$1.20 M(-14.3%) | -$3.60 M(+5.9%) |
| Dec 1992 | -$3.40 M(+88.9%) | -$1.40 M(+1300.0%) | -$3.40 M(+70.0%) |
| Sep 1992 | - | -$100.00 K(-88.9%) | -$2.00 M(+5.3%) |
| Jun 1992 | - | -$900.00 K(-10.0%) | -$1.90 M(+90.0%) |
| Mar 1992 | - | -$1.00 M | -$1.00 M |
| Dec 1991 | -$1.80 M(+1700.0%) | - | - |
| Dec 1990 | -$100.00 K | - | - |
FAQ
- What is Viveve Medical annual free cash flow?
- What is the all time high annual FCF for Viveve Medical?
- What is Viveve Medical annual FCF year-on-year change?
- What is Viveve Medical quarterly free cash flow?
- What is the all time high quarterly FCF for Viveve Medical?
- What is Viveve Medical quarterly FCF year-on-year change?
- What is Viveve Medical TTM free cash flow?
- What is the all time high TTM FCF for Viveve Medical?
- What is Viveve Medical TTM FCF year-on-year change?
What is Viveve Medical annual free cash flow?
The current annual FCF of VIVE is -$13.33 M
What is the all time high annual FCF for Viveve Medical?
Viveve Medical all-time high annual free cash flow is $3.18 M
What is Viveve Medical annual FCF year-on-year change?
Over the past year, VIVE annual free cash flow has changed by +$2.68 M (+16.74%)
What is Viveve Medical quarterly free cash flow?
The current quarterly FCF of VIVE is -$3.54 M
What is the all time high quarterly FCF for Viveve Medical?
Viveve Medical all-time high quarterly free cash flow is $6.94 M
What is Viveve Medical quarterly FCF year-on-year change?
Over the past year, VIVE quarterly free cash flow has changed by -$796.00 K (-28.98%)
What is Viveve Medical TTM free cash flow?
The current TTM FCF of VIVE is -$16.83 M
What is the all time high TTM FCF for Viveve Medical?
Viveve Medical all-time high TTM free cash flow is $7.91 M
What is Viveve Medical TTM FCF year-on-year change?
Over the past year, VIVE TTM free cash flow has changed by -$4.34 M (-34.73%)